A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy (Q50072990)

24 February 2018

title

A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy (English)

1 reference

24 February 2018

1 reference

Zhenzhen Wang

1 reference

24 February 2018

Yan Zhang

1 reference

24 February 2018

Zhen Liu

1 reference

24 February 2018

Kai Dong

1 reference

24 February 2018

Chaoqun Liu

1 reference

24 February 2018

Xiang Ran

1 reference

24 February 2018

Fang Pu

1 reference

24 February 2018

Enguo Ju

1 reference

24 February 2018

Jinsong Ren

1 reference

24 February 2018

Xiaogang Qu

1 reference

24 February 2018

language of work or name

English

0 references

publication date

15 September 2017

1 reference

24 February 2018

published in

Nanoscale

1 reference

24 February 2018

volume

1 reference

24 February 2018

issue

1 reference

24 February 2018

page(s)

14236-14247

1 reference

24 February 2018

Designer vaccine nanodiscs for personalized cancer immunotherapy

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Structure-based programming of lymph-node targeting in molecular vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Passivation Using Molecular Halides Increases Quantum Dot Solar Cell Performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

The future of CpG immunotherapy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Organosilane and Polyethylene Glycol Functionalized Magnetic Mesoporous Silica Nanoparticles as Carriers for CpG Immunotherapy In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

T cell exclusion, immune privilege, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Membrane anchored immunostimulatory oligonucleotides for in vivo cell modification and localized immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

The interplay of immunotherapy and chemotherapy: harnessing potential synergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Rationale for combining immunotherapy with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Immunogenic death of colon cancer cells treated with oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Induction of immunogenic cell death by chemotherapeutic platinum complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Chemotherapy in the management of advanced cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Highly Integrated Nano-Platform for Breaking the Barrier between Chemotherapy and Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Molecular characteristics of immunogenic cancer cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Activatable fluorescence/MRI bimodal platform for tumor cell imaging via MnO2 nanosheet-aptamer nanoprobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Break-up of two-dimensional MnO2 nanosheets promotes ultrasensitive pH-triggered theranostics of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Intracellular glutathione detection using MnO(2)-nanosheet-modified upconversion nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Multivalent Polymer Nanocomplex Targeting Endosomal Receptor of Immune Cells for Enhanced Antitumor and Systemic Memory Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

In vivo gold nanoparticle delivery of peptide vaccine induces anti-tumor immune response in prophylactic and therapeutic tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Lanthanide-based hollow mesoporous nanoparticles: a novel multifunctional platform for simultaneous gene delivery and cell imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Metal nanoclusters: novel probes for diagnostic and therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

Polyvalent Immunostimulatory Nanoagents with Self-Assembled CpG Oligonucleotide-Conjugated Gold Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR04396A

21 January 2018

Identifiers

DOI

10.1039/C7NR04396A

1 reference

24 February 2018

1 reference

24 February 2018